Predictive Oncology Statistics
Total Valuation
POAI has a market cap or net worth of $14.46 million. The enterprise value is $16.17 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
POAI has 3.39 million shares outstanding. The number of shares has increased by 76.22% in one year.
| Current Share Class | 3.39M |
| Shares Outstanding | 3.39M |
| Shares Change (YoY) | +76.22% |
| Shares Change (QoQ) | +19.22% |
| Owned by Insiders (%) | 38.38% |
| Owned by Institutions (%) | 0.94% |
| Float | 1.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.44 |
| Forward PS | 2.83 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -169.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -128.80% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.35% |
| Revenue Per Employee | $69,350 |
| Profits Per Employee | -$3.51M |
| Employee Count | 24 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 3.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.72% in the last 52 weeks. The beta is 1.35, so POAI's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -61.72% |
| 50-Day Moving Average | 9.12 |
| 200-Day Moving Average | 13.57 |
| Relative Strength Index (RSI) | 24.55 |
| Average Volume (20 Days) | 30,554 |
Short Selling Information
The latest short interest is 76,143, so 2.24% of the outstanding shares have been sold short.
| Short Interest | 76,143 |
| Short Previous Month | 42,177 |
| Short % of Shares Out | 2.24% |
| Short % of Float | 4.15% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, POAI had revenue of $1.66 million and -$84.33 million in losses. Loss per share was -$149.54.
| Revenue | 1.66M |
| Gross Profit | 814,043 |
| Operating Income | -10.96M |
| Pretax Income | -84.62M |
| Net Income | -84.33M |
| EBITDA | -10.80M |
| EBIT | -10.96M |
| Loss Per Share | -$149.54 |
Full Income Statement Balance Sheet
The company has $181,667 in cash and $1.89 million in debt, giving a net cash position of -$1.71 million or -$0.50 per share.
| Cash & Cash Equivalents | 181,667 |
| Total Debt | 1.89M |
| Net Cash | -1.71M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | -77.43M |
| Book Value Per Share | -100.94 |
| Working Capital | -78.38M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$7.88 million and capital expenditures -$6,478, giving a free cash flow of -$7.89 million.
| Operating Cash Flow | -7.88M |
| Capital Expenditures | -6,478 |
| Free Cash Flow | -7.89M |
| FCF Per Share | -$2.32 |
Full Cash Flow Statement Margins
| Gross Margin | 48.91% |
| Operating Margin | -658.44% |
| Pretax Margin | -5,084.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |